
"NUTX: Micro-hospital operator w/ 220.7% Q2 rev growth to $244M, 51.1% gross margin, $71.6M adj EBITDA. 21 facilities opened 2024, <30min wait vs 100+ at traditional ERs. Trades 8x P/E, 3.8x EV/EBITDA. Risks: regulatory changes, competition from large hospital chains, physician dilution."
Nutex Health: On the way to becoming a hidden champion in healthcare!
TopSecretStocks
September 27, 2025
Stock Idea